Cardiovascular abnormalities, interventions, and long-term outcomes in infantile Williams syndrome

R Thomas Collins1, Paige Kaplan, Grant W Somes

  • 1The Cardiac Center, The Children's Hospital of Philadelphia, 8th Floor, Main Building, 34th Street and Civic Center Boulevard, Philadelphia, PA 19104, USA. collinsr@email.chop.edu

The Journal of Pediatrics
|October 23, 2009
PubMed

Insights

Cardiovascular abnormalities are common in infants with Williams syndrome (WS). While many patients with WS require interventions by age 5, most do not need long-term treatment, and overall mortality is low.

Area of Science:

  • Cardiology
  • Genetics
  • Pediatrics

Background:

  • Williams syndrome (WS) is a genetic disorder associated with cardiovascular abnormalities (CVA).
  • Early identification and management of CVA in WS are crucial for patient outcomes.

Purpose of the Study:

  • To determine the prevalence of CVA in infants with WS presenting before one year of age.
  • To evaluate the long-term outcomes and intervention requirements for these patients.

Main Methods:

  • Retrospective review of 129 patients diagnosed with WS.
  • Diagnosis of CVA using echocardiography, cardiac catheterization, or CT angiography.
  • Kaplan-Meier analysis to assess freedom from intervention.

Main Results:

  • The most frequent CVA were peripheral pulmonary artery stenosis (62%) and supravalvar aortic stenosis (57%).
  • Cardiovascular interventions were performed in 29% of patients, with 58% occurring before age 1.
  • Freedom from intervention was 85% at 1 year, 73% at 5 years, and 66% at 25 years.

Conclusions:

  • CVA are highly prevalent in infantile WS, occurring more frequently than previously reported.
  • Interventions for CVA are common in early childhood but not typically required long-term.
  • Overall mortality in patients with WS and CVA is low.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...